Ji‐Yeon Kim

2.4k total citations
113 papers, 1.4k citations indexed

About

Ji‐Yeon Kim is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ji‐Yeon Kim has authored 113 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 42 papers in Cancer Research and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ji‐Yeon Kim's work include Breast Cancer Treatment Studies (29 papers), HER2/EGFR in Cancer Research (23 papers) and Advanced Breast Cancer Therapies (20 papers). Ji‐Yeon Kim is often cited by papers focused on Breast Cancer Treatment Studies (29 papers), HER2/EGFR in Cancer Research (23 papers) and Advanced Breast Cancer Therapies (20 papers). Ji‐Yeon Kim collaborates with scholars based in South Korea, United States and Puerto Rico. Ji‐Yeon Kim's co-authors include Young‐Hyuck Im, Yeon Hee Park, Jin Seok Ahn, Hae Hyun Jung, Seok Won Kim, Seok Jin Nam, Ji Eun Lim, Woong‐Yang Park, Kyunghee Park and Jeong Eon Lee and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Physical Review B.

In The Last Decade

Ji‐Yeon Kim

99 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ji‐Yeon Kim South Korea 23 523 414 414 287 184 113 1.4k
Linda E. Kelemen United States 27 638 1.2× 632 1.5× 353 0.9× 240 0.8× 81 0.4× 55 2.2k
Maria P. Morgan Ireland 19 377 0.7× 386 0.9× 178 0.4× 145 0.5× 182 1.0× 33 1.2k
Jiayu Wang China 21 709 1.4× 479 1.2× 512 1.2× 368 1.3× 93 0.5× 112 1.4k
Cuizhi Geng China 24 579 1.1× 689 1.7× 579 1.4× 310 1.1× 141 0.8× 133 1.6k
Gregory D. Leonard United States 13 1.4k 2.6× 517 1.2× 286 0.7× 235 0.8× 106 0.6× 30 2.0k
Yu Jiang China 19 219 0.4× 389 0.9× 172 0.4× 170 0.6× 88 0.5× 67 1.1k
Qianming Bai China 20 314 0.6× 412 1.0× 203 0.5× 171 0.6× 183 1.0× 82 1.2k
Mohammad Hossein Kazemi Iran 14 398 0.8× 484 1.2× 240 0.6× 156 0.5× 59 0.3× 38 1.2k

Countries citing papers authored by Ji‐Yeon Kim

Since Specialization
Citations

This map shows the geographic impact of Ji‐Yeon Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji‐Yeon Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji‐Yeon Kim more than expected).

Fields of papers citing papers by Ji‐Yeon Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji‐Yeon Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji‐Yeon Kim. The network helps show where Ji‐Yeon Kim may publish in the future.

Co-authorship network of co-authors of Ji‐Yeon Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Ji‐Yeon Kim. A scholar is included among the top collaborators of Ji‐Yeon Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji‐Yeon Kim. Ji‐Yeon Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Seok Won, Jong Han Yu, Se Kyung Lee, et al.. (2025). Real-world evidence of the efficacy of neoadjuvant pembrolizumab in triple-negative breast cancer: A surgeon's point of view. European Journal of Surgical Oncology. 51(8). 110011–110011.
2.
Park, Yeon Hee, Kyung-Hun Lee, Gun Min Kim, et al.. (2024). Palbociclib plus exemestane with GnRH agonist vs capecitabine in premenopausal patients with HR+/HER2- metastatic breast cancer: Updated survival results of the randomized phase 2 study Young-PEARL.. Journal of Clinical Oncology. 42(17_suppl). LBA1002–LBA1002. 1 indexed citations
3.
Kim, Ji‐Yeon, et al.. (2024). Resistance to thyroid hormone and nonfunctioning pituitary microadenoma in a 13-year-old boy with THRB mutation. Annals of Pediatric Endocrinology & Metabolism. 29(1). 67–69.
4.
Song, Kyoung, Jie Song, Mi‐Sook Lee, et al.. (2024). Real-time assessment of relative mitochondrial ATP synthesis response against inhibiting and stimulating substrates (MitoRAISE). SHILAP Revista de lepidopterología. 12(1). 25–25.
5.
Park, Jieun, Ji‐Yeon Kim, Chaithanya Chelakkot, et al.. (2024). c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer. Breast Cancer Research. 26(1). 13–13. 12 indexed citations
6.
Park, Seongyeol, Ryul Kim, Baek‐Lok Oh, et al.. (2023). Comprehensive profiling of mutational signatures and machine learning and subtypes of homologous recombination deficiency.. Journal of Clinical Oncology. 41(16_suppl). 568–568. 1 indexed citations
7.
Kim, Nalee, Haeyoung Kim, Won Park, et al.. (2023). Impact of high dose radiotherapy for breast tumor in locoregionally uncontrolled stage IV breast cancer: a need for a risk-stratified approach. Radiation Oncology. 18(1). 3 indexed citations
8.
9.
Cho, Sung Yoon, Danbee Kang, Aram Yang, et al.. (2022). Development and validation of the Pediatric-Youth Hyperphagia Assessment for Prader-Willi syndrome. Epidemiology and Health. 44. e2022014–e2022014. 3 indexed citations
10.
Park, Yeon Hee, Vassiliki Karantza, Seri Park, et al.. (2021). Prevalence, treatment patterns, and prognosis of low estrogen receptor-positive (1% to 10%) breast cancer: a single institution’s experience in Korea. Breast Cancer Research and Treatment. 189(3). 653–663. 10 indexed citations
11.
Kim, Ji‐Yeon, et al.. (2021). Wilson disease diagnosed incidentally by targeted gene panel sequencing in a Korean boy with severe obesity. Annals of Pediatric Endocrinology & Metabolism. 27(3). 229–235. 1 indexed citations
12.
Park, Hyojung, Min-Sun Kim, Ji‐Yeon Kim, et al.. (2021). Hypertriglyceridemia with acute pancreatitis in a 14-year-old girl with diabetic ketoacidosis. Annals of Pediatric Endocrinology & Metabolism. 27(1). 73–77. 2 indexed citations
13.
Kim, Ji‐Yeon, et al.. (2020). Effects of probiotics on fiber depleted rat gut microbiota. 56(2). 118–125. 1 indexed citations
14.
Park, Sehhoon, Eunjin Lee, Seri Park, et al.. (2020). Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast Cancer. Molecular Cancer Research. 18(9). 1315–1325. 11 indexed citations
15.
16.
Kim, Ji‐Yeon, et al.. (2019). Relationship Between Prevalence of Allergic Diseases and Recognition of Food Nutrition Labeling. The Journal of the Korea Contents Association. 19(11). 434–444.
17.
Noh, Youngmin, et al.. (2019). Factors Affecting Intention to Quit Smoking of Current Smokers by Gender. The Journal of the Korea Contents Association. 19(9). 321–328. 2 indexed citations
18.
Kim, Ji‐Yeon, et al.. (2018). Association between Smoking Cessation Attempts and Perceived Stress Level : the Korea National Health and Nutrition Examination Survey 2015. Journal of the Korean Chemical Society. 9(9). 285–292. 1 indexed citations
19.
Lee, Hyun‐Sook, Oran Kwon, Joo‐Hee Kim, et al.. (2009). Demands of Education Programs for Evaluation of the Efficacy of Health Functional Foods. Journal of the Korean Society of Food Culture. 24(3). 331–337. 1 indexed citations
20.
Kim, Ji‐Yeon, et al.. (2006). The influence of obesity on pediatric conscious sedation. THE JOURNAL OF THE KOREAN ACADEMY OF PEDTATRIC DENTISTRY. 33(1). 62–69. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda E. Kelemen Breakdown of academic impact, for papers by Maria P. Morgan Breakdown of academic impact, for papers by Jiayu Wang Breakdown of academic impact, for papers by Cuizhi Geng Breakdown of academic impact, for papers by Gregory D. Leonard Breakdown of academic impact, for papers by Yu Jiang Breakdown of academic impact, for papers by Qianming Bai Breakdown of academic impact, for papers by Mohammad Hossein Kazemi
Rankless by CCL
2026